Search Medical Condition
Please enter condition
Please choose location from dropdown

Hepatitis Clinical Trials

A listing of Hepatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (485) clinical trials

The purpose of this study is to find out how safe and effective OCA may be in delaying or preventing specific medical conditions or health related issues that can occur in patients with NASH and evidence of liver fibrosis. The investigational drug, OCA, is a modified (man-made) version of a ...

Phase

A research study is evaluating new testing methodologies of blood samples in patients with Hepatitis C. This research study may be an option if you: Are at least 18 years of age Weigh at least 110 pounds Have been diagnosed with, or are suspected to have Hepatitis C Are about ...

Phase N/A

People with Hepatitis C Virus are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

Nonalcoholic steatohepatitis (NASH) is an advanced form of fatty liver disease. It is caused by excess fat in the liver that leads to inflammation and tissue injury. People with type 2 diabetes, obesity, high cholesterol, insulin resistance, and high blood pressure may have NASH. ACRC Trials is conducting a research ...

Phase

The body’s immune system usually becomes active when the body is fighting off an infection or disease. If an immune system is active for a long period of time, it may lead to problems such as heart, liver, and kidney disease. Many people who inject drugs are also infected with ...

Phase N/A

Hepatitis C is an infectious disease affecting primarily the liver, caused by the hepatitis C virus (HCV). HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment and transfusions. An estimated 150-200 million people worldwide are infected with hepatitis C. The infection is often ...

Phase N/A

To explore the antiviral efficacy of combination therapy with sofosbuvir/ledipasvir fixed-dose combination ribavirin for 12 or 24 weeks in patients with advanced liver disease. Study designed with A cohort and B cohort.

Phase N/A

The purpose of this study is to evaluate the safety and effectiveness of an FDA-approved study drug as a sleep aid as compared to placebo (an inactive substance) in the treatment of insomnia associated with interferon-induced insomnia in patients with chronic hepatitis C (CHC). In addition, another purpose of this ...

Phase N/A

This is a study for an investigational vaccine for Hepatitis B.

Phase

Evaluation of Patients With Liver Disease

This is a general clinical research protocol to allow for evaluation, investigation and long-term follow up of patients who have an acute or chronic liver disease. The protocol is designed to study the natural history and pathogenesis of various liver diseases such as acute and chronic hepatitis B, C, D ...

Phase N/A